GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Metropolis Healthcare Ltd

Metropolis Healthcare Q2 FY27 Standalone Profit Rs. 687.51 million, Declares Interim Dividend

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Nov 2026, 07:24 PM IST  ·  BSE ID: e12297bf-5d32-4a94-83d4-359fe39ea5b3
View Original BSE Filing (PDF)
💡
In Simple Terms
Metropolis Healthcare reported higher quarterly profit and revenue, also announcing a dividend for its shareholders.
🤖 AI Summary
  • Standalone net profit from continuing operations was Rs. 687.51 million for the quarter ended September 30, 2026 (Q2 FY27).
  • Revenue from operations reached Rs. 4,169.34 million in Q2 FY27, compared to Rs. 3,554.57 million in Q2 FY26.
  • Interim Dividend of INR 1/- per equity share (face value INR 2/-) declared for the financial year 2026-27.
  • Record date for the interim dividend is Monday, November 09, 2026; payment to be made within 30 days of declaration.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
4,169.34 million
17.29
Profit for the period from continuing operations (Q2 FY27)
687.51 million
47.88
Total Income (Q2 FY27)
4,259.22 million
18.98
Basic Earnings per share from continuing operation (Q2 FY27)
3.32 Rs.
47.56
🏢 How This Affects the Company
📈
Business Impact
Revenue from operations for the quarter increased to Rs. 4,169.34 million, indicating growth in its core pathology services segment.
💰
Financial Impact
Profit for the period from continuing operations rose to Rs. 687.51 million, contributing to a total comprehensive income of Rs. 684.61 million.
⚙️
Operational Impact
The transfer of the EQAS division to Metropolis Quality Solutions Private Limited was effective August 27, 2026, streamlining operations to focus on core pathology services.
👥 What This Means For Shareholders
✅
Action Required
Shareholders who wish to receive the interim dividend must ensure their shares are held on or before the record date of Monday, November 09, 2026.
👤
Who Is Affected
Shareholders holding equity shares of face value INR 2/- each will receive INR 1/- per share as an interim dividend. This applies to 20,75,28,996 shares outstanding.
🔍
Management Signal
The declaration of an interim dividend and strong financial results signal management's confidence in the company's profitability and commitment to shareholder returns for FY27.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — assess sustained revenue and profit growth.
Dividend payment date — verify timely disbursement of interim dividend.
Updates on core pathology services expansion initiatives.
LOW RISK The filing indicates strong financial performance and a dividend declaration.
💡 Investor Takeaway
Metropolis Healthcare's Q2 FY27 standalone net profit from continuing operations increased to Rs. 687.51 million, up 47.88% from Rs. 464.90 million in Q2 FY26. Revenue from operations rose 17.29% to Rs. 4,169.34 million. An interim dividend of INR 1/- per equity share was declared for FY27.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue from operations increased by 17.29% to Rs. 4,169.34 million in Q2 FY27 from Rs. 3,554.57 million in Q2 FY26.
  • Profit for the period from continuing operations grew by 47.88% to Rs. 687.51 million in Q2 FY27 from Rs. 464.90 million in Q2 FY26.

⚠️ Concerns

  • Other comprehensive income/(loss) for the period was a loss of Rs. 2.90 million in Q2 FY27, compared to a loss of Rs. 23.75 million in Q2 FY26.
  • The discontinued operations reported a loss of Rs. 0.71 million for Q2 FY27, impacting the total profit for the period.
📅 Company Track Record
Metropolis Healthcare previously reported Q1 FY27 net profit of Rs. 505.83 million and revenue of Rs. 3,722.84 million, indicating a consistent upward trend in financial performance year-on-year. The company had also issued 15,54,95,826 Bonus Equity Shares in the ratio of 3:1 in FY26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Metropolis Healthcare's standalone net profit in Q2 FY27?
Metropolis Healthcare reported a standalone net profit from continuing operations of Rs. 687.51 million for the quarter ended September 30, 2026 (Q2 FY27).
What was Metropolis Healthcare's revenue from operations for Q2 FY27?
Revenue from operations for Metropolis Healthcare in Q2 FY27 stood at Rs. 4,169.34 million, an increase from Rs. 3,554.57 million in Q2 FY26.
What interim dividend did Metropolis Healthcare declare for FY27?
Metropolis Healthcare declared an Interim Dividend of INR 1/- per equity share (face value INR 2/-) for the financial year 2026-27.
When is the record date for Metropolis Healthcare's interim dividend?
The record date for the interim dividend declared by Metropolis Healthcare is Monday, November 09, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.